<DOC>
	<DOCNO>NCT02970019</DOCNO>
	<brief_summary>This safety , tolerability pharmacokinetic study subject Parkinson 's disease</brief_summary>
	<brief_title>Safety Tolerability Study K0706 Subjects With Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>1 . Willing able give write , date , inform consent ( legally acceptable representative/impartial witness applicable ) available entire study 2 . Willing able comply schedule visit , treatment plan , laboratory testing , study procedure , restriction ( Investigator 's opinion ) , accessible followup 3 . Male female age 18 65 year ( inclusive ) 4 . Diagnosed Parkinson 's disease 1 . Clinical diagnosis genetic form Parkinson 's disease , druginduced parkinsonism 2 . Diagnosis Parkinson 's disease Dementia ( probable , possible ) 3 . Presence severe dyskinesia 4 . History brain surgery Parkinson 's disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>